Logo image of BLCT

BLUECITY HOLDINGS LTD-ADR (BLCT) Stock Fundamental Analysis

NASDAQ:BLCT - Nasdaq - US09610L1061 - ADR - Currency: USD

1.54  0 (0%)

After market: 1.54 0 (0%)

Fundamental Rating

3

Taking everything into account, BLCT scores 3 out of 10 in our fundamental rating. BLCT was compared to 71 industry peers in the Interactive Media & Services industry. BLCT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BLCT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BLCT has reported negative net income.
BLCT Yearly Net Income VS EBIT VS OCF VS FCFBLCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -50.74%
ROE N/A
ROIC -34.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLCT Yearly ROA, ROE, ROICBLCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -18.65%
PM (TTM) -28.76%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLCT Yearly Profit, Operating, Gross MarginsBLCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 20 -20

More info and screens

6

2. Health

2.1 Basic Checks

BLCT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BLCT remains at a similar level compared to 1 year ago.
There is no outstanding debt for BLCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BLCT Yearly Shares OutstandingBLCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 5M 10M 15M 20M
BLCT Yearly Total Debt VS Total AssetsBLCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

BLCT has an Altman-Z score of -1.63. This is a bad value and indicates that BLCT is not financially healthy and even has some risk of bankruptcy.
BLCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.63
ROIC/WACC-3.56
WACC9.74%
BLCT Yearly LT Debt VS Equity VS FCFBLCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 200M -200M 400M 600M

2.3 Liquidity

BLCT has a Current Ratio of 3.08. This indicates that BLCT is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 3.04 indicates that BLCT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 3.04
BLCT Yearly Current Assets VS Current LiabilitesBLCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for BLCT have decreased strongly by -35.98% in the last year.
Looking at the last year, BLCT shows a small growth in Revenue. The Revenue has grown by 4.39% in the last year.
BLCT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.02% yearly.
EPS 1Y (TTM)-35.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
Revenue 1Y (TTM)4.39%
Revenue growth 3Y29.02%
Revenue growth 5YN/A
Sales Q2Q%-12.63%

3.2 Future

The Earnings Per Share is expected to grow by 14.03% on average over the next years. This is quite good.
Based on estimates for the next years, BLCT will show a quite strong growth in Revenue. The Revenue will grow by 17.56% on average per year.
EPS Next Y34.41%
EPS Next 2Y36.85%
EPS Next 3Y21.73%
EPS Next 5Y14.03%
Revenue Next Year16.48%
Revenue Next 2Y18.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.56%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLCT Yearly Revenue VS EstimatesBLCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BLCT Yearly EPS VS EstimatesBLCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLCT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLCT Price Earnings VS Forward Price EarningsBLCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.2
BLCT Per share dataBLCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

BLCT's earnings are expected to grow with 21.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.85%
EPS Next 3Y21.73%

More info and screens

0

5. Dividend

5.1 Amount

BLCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUECITY HOLDINGS LTD-ADR

NASDAQ:BLCT (8/12/2022, 9:44:06 PM)

After market: 1.54 0 (0%)

1.54

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)07-29 2022-07-29
Earnings (Next)08-22 2022-08-22
Inst Owners8.07%
Inst Owner Change-31.61%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.80M
Analysts43.33
Price Target2.04 (32.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB N/A
EV/EBITDA -0.2
EPS(TTM)-1.94
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.28
BVpS1.77
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.74%
ROE N/A
ROCE N/A
ROIC -34.64%
ROICexc N/A
ROICexgc -47.79%
OM -18.65%
PM (TTM) -28.76%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 3.04
Altman-Z -1.63
F-Score4
WACC9.74%
ROIC/WACC-3.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
EPS Next Y34.41%
EPS Next 2Y36.85%
EPS Next 3Y21.73%
EPS Next 5Y14.03%
Revenue 1Y (TTM)4.39%
Revenue growth 3Y29.02%
Revenue growth 5YN/A
Sales Q2Q%-12.63%
Revenue Next Year16.48%
Revenue Next 2Y18.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.56%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A